Home
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Blood Glucose Articles
Popular Blood Glucose Articles
Highly Recommended Blood Glucose Articles
Email to a Friend
Send a link to this page to your friends and colleagues.
Letters from Readers
Troglitazone is a new insulin-action enhancer currently in the third phase of clinical testing. Parke-Davis Pharmaceutical Research has announced that a pilot study at St. Joseph Hospital in Ann Arbor, Mich., showed that the drug lowers blood glucose levels in patients with type 2 diabetes. The study also found that the drug can help reduce and even eliminate daily insulin injections in type 2 diabetics.
Troglitazone was given to 17 patients who were not able to control their type 2 diabetes with diet or oral medications and whose blood glucose levels fluctuated even with insulin therapy. Within 12 weeks, the patients were able to decrease their insulin dosages an average of 65%. Seven of the participants were able to completely discontinue their insulin regimen, and after the study concluded, two more patients were able to quit using insulin while taking troglitazone.
Jeffrey Sanfield, MD, principal investigator of the study, says, "An insulin action enhancer like troglitazone could go a long way in helping people control their diabetes, as well as reducing associated healthcare costs."
The drug was codeveloped by Parke-Davis Pharmaceutical Research, a division of Sankyo U.S.A. and Warner-Lambert Company. Several studies of troglitazone are taking place, and the drug will most likely be presented to the FDA sometime in 1996.
Categories: Blood Glucose, Diabetes, Insulin, Letters to the Editor, Medications Research, Type 2 Issues
You May Also Be Interested In...
-
Diabetes Health
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
-
Topics
- Diabetic / Diabetes Health
- Type 1 / 1.5 Diabetes
- Type 2 Diabetes
- Blood Glucose / Sugar
- High/Low Blood Sugar / Fast Acting Glucose
- Insulin- Pumps, Pens & Syringes
- Continuous Glucose Monitors, CGM, Infusion Sets
- Type 2 Medications
- Hyperglycemia
- Hypoglycemia
Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...